Parkinson's Disease Trial, Recruiting NCT03402919 Sponsor: McGill University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT03402919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have noticed memory or thinking problems yourself, or a doctor has identified some during testing
  • You (or a family member/caregiver, where legally permitted) are willing and able to sign a consent form agreeing to take part
  • You can speak and understand English or French well enough to complete questionnaires and thinking/memory tests
  • You live close enough to the study location to attend visits
  • You have someone (such as a family member or close friend) who can attend parts of the study with you and answer questions about you
  • You have up to 12 years of formal education
  • You fall into one of these groups: no thinking problems, self-noticed thinking problems, mild thinking or memory problems, mild thinking or memory problems related to blood flow in the brain, Parkinson's disease, or Parkinson's disease with mild thinking or memory problems

Who may not be able to join:

  • You have another significant long-term brain condition, such as a serious previous brain injury, multiple sclerosis, a serious developmental disability, a brain tumour, or certain other rare brain illnesses (confirm with trial site)
  • You are currently struggling with alcohol or drug misuse in a way that the study doctor believes could affect your ability to take part properly
  • You have had a stroke with noticeable symptoms within the past year
  • You are unable to have an MRI scan, either for medical reasons or because you are unable to tolerate the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Borrie, MD, Western University

Phone: 514 340 8222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University
Registry
ClinicalTrials.gov
Start date
1 June 2016
Est. completion
1 November 2023

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Montreal Cognitive Assessment (MoCA) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov